WASHINGTON — Like a friendly Pied Piper, the violinist keeps up a toe-tapping beat as dancers weave through busy hospital hallways and into the chemotherapy unit, patients looking up in surprised delight. Upstairs, a cellist strums an Irish folk tune for a patient in intensive care.
You are here
By Lauran Neergaard The Associated Press
WASHINGTON — Breast cancer treatment left Susan Wolfe-Tank with an arm too painfully swollen to lift anything heavy or even fit into her usual clothing a debilitating condition that gets little attention and has no cure.
WASHINGTON — Diagnosing if a tick bite caused Lyme or another disease can be difficult but scientists are developing a new way to do it early ‚Äî using a “signature” of molecules in patients’ blood.
WASHINGTON — Altering human heredity? In a first, researchers safely repaired a disease-causing gene in human embryos, targeting a heart defect best known for killing young athletes a big step toward one day preventing a list of inherited diseases.
WASHINGTON — Sen. John McCain’s tumour is one of the most aggressive forms of brain cancer, and his family and doctors are deliberating next treatment options.
The senator had undergone surgery last week to have a blood clot removed from above his left eye, and that clot turned out to be a sign that a tumour called a glioblastoma had begun growing.
WASHINGTON — There are no proven ways to stave off Alzheimer’s, but a new report raises the prospect that avoiding nine key risks starting in childhood just might delay or even prevent about a third of dementia cases around the world.
WASHINGTON — Does it really take an expensive brain scan to diagnose Alzheimer’s? Not everybody needs one but new research suggests that for a surprising number of patients whose memory problems are hard to pin down, PET scans may lead to changes in treatment.
WASHINGTON — Colon cancer. Uterine cancer. Pancreatic cancer. Whatever the tumour, the more gene mutations lurking inside, the better chance your immune system has to fight back.
WASHINGTON — An experimental drug is showing promise against an untreatable eye disease that blinds older adults and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.
SEATTLE — Ken Shefveland’s body was swollen with cancer, treatment after treatment failing until doctors gambled on a radical approach: They removed some of his immune cells, engineered them into cancer assassins and unleashed them into his bloodstream.